Gene Symbol | Gene ID | Gene Info |
---|---|---|
MYBL2
|
ENSG00000101057.11 | MYB proto-oncogene like 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr20_42310599_42310941 | MYBL2 | 14973 | 0.200298 | 0.53 | 1.4e-01 | Click! |
chr20_42298034_42298185 | MYBL2 | 2312 | 0.328936 | -0.43 | 2.5e-01 | Click! |
chr20_42286360_42287082 | MYBL2 | 9033 | 0.212153 | 0.26 | 4.9e-01 | Click! |
chr20_42310147_42310298 | MYBL2 | 14425 | 0.201573 | 0.22 | 5.7e-01 | Click! |
chr20_42295332_42295503 | MYBL2 | 337 | 0.900496 | 0.20 | 6.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_16478953_16479699 | 1.08 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
6562 |
0.16 |
chr1_169668211_169668481 | 0.93 |
SELL |
selectin L |
12493 |
0.19 |
chr1_46009773_46010134 | 0.77 |
AKR1A1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
6262 |
0.15 |
chr5_156697955_156698214 | 0.74 |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
1722 |
0.28 |
chr10_97723622_97723991 | 0.73 |
CC2D2B |
coiled-coil and C2 domain containing 2B |
9980 |
0.17 |
chr22_24037515_24037890 | 0.73 |
RGL4 |
ral guanine nucleotide dissociation stimulator-like 4 |
969 |
0.43 |
chr16_12173089_12173423 | 0.72 |
RP11-276H1.3 |
|
10903 |
0.16 |
chr22_17598280_17598546 | 0.70 |
CECR6 |
cat eye syndrome chromosome region, candidate 6 |
3730 |
0.18 |
chr13_99930486_99930694 | 0.68 |
GPR18 |
G protein-coupled receptor 18 |
16592 |
0.18 |
chr11_117844189_117844444 | 0.67 |
IL10RA |
interleukin 10 receptor, alpha |
12747 |
0.18 |
chrX_13068365_13068668 | 0.66 |
FAM9C |
family with sequence similarity 9, member C |
5715 |
0.29 |
chr3_194883641_194883957 | 0.64 |
XXYLT1 |
xyloside xylosyltransferase 1 |
12603 |
0.14 |
chr12_4939072_4939447 | 0.63 |
RP3-377H17.2 |
|
8862 |
0.2 |
chr16_1609129_1609769 | 0.62 |
LA16c-425C2.1 |
|
20860 |
0.08 |
chr4_80525491_80525669 | 0.61 |
OR7E94P |
olfactory receptor, family 7, subfamily E, member 94 pseudogene |
16296 |
0.29 |
chr8_142414659_142415118 | 0.61 |
CTD-3064M3.4 |
|
12214 |
0.12 |
chr22_26899384_26900019 | 0.60 |
TFIP11 |
tuftelin interacting protein 11 |
2597 |
0.19 |
chr12_92798098_92798558 | 0.60 |
RP11-693J15.4 |
|
16979 |
0.18 |
chr5_75839527_75840273 | 0.60 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
3334 |
0.31 |
chr12_11923043_11923437 | 0.59 |
ETV6 |
ets variant 6 |
17805 |
0.27 |
chr6_167533760_167534243 | 0.59 |
CCR6 |
chemokine (C-C motif) receptor 6 |
2256 |
0.3 |
chr18_13377615_13378173 | 0.59 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
4659 |
0.18 |
chrX_38528694_38528973 | 0.58 |
ENSG00000238606 |
. |
61365 |
0.14 |
chr6_131520209_131520483 | 0.58 |
AKAP7 |
A kinase (PRKA) anchor protein 7 |
785 |
0.78 |
chr6_131522166_131522407 | 0.58 |
AKAP7 |
A kinase (PRKA) anchor protein 7 |
319 |
0.94 |
chr12_9915687_9916017 | 0.57 |
CD69 |
CD69 molecule |
2355 |
0.25 |
chr2_134921204_134921741 | 0.57 |
ENSG00000263813 |
. |
36776 |
0.18 |
chr7_50356212_50356462 | 0.57 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
8019 |
0.29 |
chr9_20209161_20209561 | 0.56 |
ENSG00000221744 |
. |
85641 |
0.1 |
chr5_169065127_169065524 | 0.56 |
DOCK2 |
dedicator of cytokinesis 2 |
1074 |
0.61 |
chr10_6586306_6586575 | 0.56 |
PRKCQ |
protein kinase C, theta |
35761 |
0.23 |
chr9_86908771_86909182 | 0.56 |
RP11-380F14.2 |
|
15842 |
0.25 |
chr12_21831996_21832380 | 0.56 |
RP11-59N23.3 |
|
16941 |
0.18 |
chr11_6768410_6768888 | 0.55 |
OR2AG2 |
olfactory receptor, family 2, subfamily AG, member 2 |
21637 |
0.11 |
chr2_25508000_25508456 | 0.55 |
DNMT3A |
DNA (cytosine-5-)-methyltransferase 3 alpha |
33048 |
0.17 |
chr4_154350453_154350683 | 0.55 |
KIAA0922 |
KIAA0922 |
36930 |
0.15 |
chrX_42793320_42793618 | 0.55 |
MAOA |
monoamine oxidase A |
721998 |
0.0 |
chr17_48474042_48474255 | 0.54 |
RP1-117B12.4 |
|
349 |
0.64 |
chr13_51467249_51467539 | 0.54 |
RNASEH2B-AS1 |
RNASEH2B antisense RNA 1 |
1616 |
0.39 |
chr3_71504799_71505333 | 0.54 |
ENSG00000221264 |
. |
86174 |
0.09 |
chr9_92097148_92097521 | 0.54 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
2529 |
0.33 |
chrX_71317073_71317224 | 0.54 |
RGAG4 |
retrotransposon gag domain containing 4 |
34530 |
0.14 |
chr2_46577756_46578032 | 0.54 |
EPAS1 |
endothelial PAS domain protein 1 |
53353 |
0.14 |
chr2_235392806_235393340 | 0.53 |
ARL4C |
ADP-ribosylation factor-like 4C |
12171 |
0.32 |
chr15_55537821_55537972 | 0.53 |
RAB27A |
RAB27A, member RAS oncogene family |
3337 |
0.28 |
chr3_16343443_16343594 | 0.53 |
RP11-415F23.2 |
|
12428 |
0.16 |
chr14_103088258_103088516 | 0.53 |
RCOR1 |
REST corepressor 1 |
29154 |
0.15 |
chrX_48570630_48571127 | 0.53 |
ENSG00000206723 |
. |
12088 |
0.11 |
chr16_56296813_56297090 | 0.53 |
ENSG00000265281 |
. |
17519 |
0.16 |
chr3_108012757_108013257 | 0.52 |
HHLA2 |
HERV-H LTR-associating 2 |
2369 |
0.35 |
chr13_99931097_99931381 | 0.52 |
GPR18 |
G protein-coupled receptor 18 |
17241 |
0.18 |
chr20_42697519_42697810 | 0.52 |
TOX2 |
TOX high mobility group box family member 2 |
14673 |
0.22 |
chr5_39207369_39207672 | 0.52 |
FYB |
FYN binding protein |
4391 |
0.32 |
chr14_61919103_61919361 | 0.52 |
PRKCH |
protein kinase C, eta |
9956 |
0.25 |
chr18_29621846_29622219 | 0.51 |
ENSG00000265063 |
. |
18920 |
0.13 |
chrX_78416581_78416753 | 0.51 |
GPR174 |
G protein-coupled receptor 174 |
9802 |
0.32 |
chr7_17340062_17340378 | 0.51 |
AC003075.4 |
|
1239 |
0.46 |
chr2_240127614_240127778 | 0.51 |
HDAC4 |
histone deacetylase 4 |
14944 |
0.17 |
chr7_116751275_116751434 | 0.51 |
ST7 |
suppression of tumorigenicity 7 |
11538 |
0.21 |
chr5_14584910_14585422 | 0.51 |
FAM105A |
family with sequence similarity 105, member A |
3282 |
0.32 |
chr2_204581966_204582117 | 0.51 |
CD28 |
CD28 molecule |
10625 |
0.24 |
chr7_102066247_102066509 | 0.51 |
ORAI2 |
ORAI calcium release-activated calcium modulator 2 |
7175 |
0.09 |
chr18_77867996_77868424 | 0.51 |
ADNP2 |
ADNP homeobox 2 |
600 |
0.76 |
chr2_225793256_225793731 | 0.50 |
DOCK10 |
dedicator of cytokinesis 10 |
18289 |
0.28 |
chr2_64447296_64447534 | 0.50 |
AC074289.1 |
|
7580 |
0.28 |
chr10_33622577_33623112 | 0.50 |
NRP1 |
neuropilin 1 |
466 |
0.87 |
chr2_44409935_44410251 | 0.50 |
PPM1B |
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
14044 |
0.17 |
chr2_85767177_85767896 | 0.50 |
MAT2A |
methionine adenosyltransferase II, alpha |
771 |
0.45 |
chrX_133522457_133522608 | 0.50 |
ENSG00000251962 |
. |
14880 |
0.17 |
chr2_173359999_173360567 | 0.50 |
ITGA6 |
integrin, alpha 6 |
7593 |
0.17 |
chr2_197065849_197066109 | 0.50 |
ENSG00000239161 |
. |
14067 |
0.18 |
chr6_167470313_167470474 | 0.50 |
CCR6 |
chemokine (C-C motif) receptor 6 |
54902 |
0.09 |
chr8_37132456_37132991 | 0.50 |
RP11-150O12.6 |
|
241816 |
0.02 |
chr9_111774656_111775198 | 0.50 |
CTNNAL1 |
catenin (cadherin-associated protein), alpha-like 1 |
852 |
0.55 |
chr1_92940522_92940749 | 0.50 |
GFI1 |
growth factor independent 1 transcription repressor |
8876 |
0.26 |
chr4_16214348_16214631 | 0.49 |
TAPT1 |
transmembrane anterior posterior transformation 1 |
13605 |
0.19 |
chr16_88765948_88766142 | 0.49 |
RNF166 |
ring finger protein 166 |
69 |
0.92 |
chr7_37384431_37384846 | 0.49 |
ELMO1 |
engulfment and cell motility 1 |
1855 |
0.37 |
chr1_9485397_9485907 | 0.49 |
ENSG00000252956 |
. |
12185 |
0.23 |
chr21_34756882_34757061 | 0.49 |
IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
18231 |
0.17 |
chr19_16228666_16229162 | 0.49 |
RAB8A |
RAB8A, member RAS oncogene family |
6207 |
0.14 |
chr7_150360680_150361171 | 0.48 |
GIMAP2 |
GTPase, IMAP family member 2 |
21863 |
0.15 |
chr1_154438061_154438451 | 0.48 |
RP11-350G8.9 |
|
14232 |
0.12 |
chr14_56616906_56617094 | 0.48 |
PELI2 |
pellino E3 ubiquitin protein ligase family member 2 |
31173 |
0.21 |
chr1_111433483_111434153 | 0.48 |
CD53 |
CD53 molecule |
18042 |
0.16 |
chr6_46097010_46097161 | 0.48 |
RP1-8B1.4 |
|
243 |
0.79 |
chr5_31517263_31517579 | 0.48 |
DROSHA |
drosha, ribonuclease type III |
9012 |
0.18 |
chr12_65076887_65077458 | 0.48 |
AC025262.1 |
Mesenchymal stem cell protein DSC96; Uncharacterized protein |
13157 |
0.14 |
chr17_56420849_56421129 | 0.48 |
BZRAP1-AS1 |
BZRAP1 antisense RNA 1 |
6270 |
0.12 |
chr15_66070362_66070791 | 0.48 |
RP11-16E23.3 |
|
10840 |
0.16 |
chrX_131151523_131151674 | 0.48 |
MST4 |
Serine/threonine-protein kinase MST4 |
5695 |
0.24 |
chr10_11223138_11223359 | 0.47 |
RP3-323N1.2 |
|
9909 |
0.22 |
chr1_236678573_236678724 | 0.47 |
LGALS8 |
lectin, galactoside-binding, soluble, 8 |
2652 |
0.24 |
chr1_211526157_211526486 | 0.47 |
TRAF5 |
TNF receptor-associated factor 5 |
6615 |
0.27 |
chr22_40309826_40310035 | 0.47 |
GRAP2 |
GRB2-related adaptor protein 2 |
12665 |
0.17 |
chr9_132708644_132709361 | 0.47 |
RP11-409K20.6 |
|
13187 |
0.19 |
chr1_111419969_111420224 | 0.47 |
CD53 |
CD53 molecule |
4320 |
0.23 |
chr2_143909211_143909819 | 0.46 |
RP11-190J23.1 |
|
20226 |
0.22 |
chr21_43843966_43844673 | 0.46 |
ENSG00000252619 |
. |
6617 |
0.14 |
chr1_26056713_26056889 | 0.46 |
MAN1C1 |
mannosidase, alpha, class 1C, member 1 |
20708 |
0.15 |
chr8_42587750_42588047 | 0.46 |
RP11-412B14.1 |
|
10809 |
0.18 |
chr3_56788277_56788649 | 0.46 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
21132 |
0.24 |
chr5_150594953_150595161 | 0.46 |
GM2A |
GM2 ganglioside activator |
3346 |
0.23 |
chr19_47223417_47223568 | 0.46 |
STRN4 |
striatin, calmodulin binding protein 4 |
2976 |
0.12 |
chr9_92022718_92022899 | 0.46 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
1967 |
0.41 |
chr2_109964621_109965051 | 0.46 |
ENSG00000265965 |
. |
34755 |
0.23 |
chr1_206738558_206738919 | 0.46 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
8245 |
0.17 |
chr1_101396926_101397104 | 0.46 |
SLC30A7 |
solute carrier family 30 (zinc transporter), member 7 |
30369 |
0.13 |
chr12_104861058_104861769 | 0.46 |
CHST11 |
carbohydrate (chondroitin 4) sulfotransferase 11 |
10634 |
0.27 |
chr5_38453846_38454268 | 0.46 |
EGFLAM |
EGF-like, fibronectin type III and laminin G domains |
5699 |
0.18 |
chr3_128836356_128836629 | 0.46 |
RAB43 |
RAB43, member RAS oncogene family |
4132 |
0.14 |
chr1_19507037_19507454 | 0.46 |
UBR4 |
ubiquitin protein ligase E3 component n-recognin 4 |
12696 |
0.16 |
chr6_33775484_33775750 | 0.46 |
MLN |
motilin |
3829 |
0.22 |
chr7_40594488_40594662 | 0.46 |
AC004988.1 |
|
8048 |
0.33 |
chr14_51279547_51280135 | 0.46 |
RP11-286O18.1 |
|
8757 |
0.15 |
chr1_117305953_117306227 | 0.46 |
CD2 |
CD2 molecule |
9001 |
0.22 |
chr1_198594201_198594564 | 0.46 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
13419 |
0.24 |
chr16_67582730_67583054 | 0.46 |
FAM65A |
family with sequence similarity 65, member A |
4595 |
0.1 |
chr9_135859081_135859232 | 0.46 |
GFI1B |
growth factor independent 1B transcription repressor |
2887 |
0.17 |
chrX_39195070_39195348 | 0.46 |
ENSG00000207122 |
. |
254671 |
0.02 |
chr18_9474647_9474843 | 0.46 |
RALBP1 |
ralA binding protein 1 |
262 |
0.91 |
chr3_27401268_27401649 | 0.46 |
ENSG00000221573 |
. |
2691 |
0.28 |
chr14_56603509_56603766 | 0.45 |
PELI2 |
pellino E3 ubiquitin protein ligase family member 2 |
17810 |
0.24 |
chr7_38262255_38262771 | 0.45 |
STARD3NL |
STARD3 N-terminal like |
44516 |
0.2 |
chr17_33359882_33360168 | 0.45 |
RFFL |
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
6438 |
0.13 |
chr12_121661223_121661628 | 0.45 |
P2RX4 |
purinergic receptor P2X, ligand-gated ion channel, 4 |
13457 |
0.17 |
chr2_62533078_62533236 | 0.45 |
ENSG00000238809 |
. |
41027 |
0.15 |
chr4_2174016_2174297 | 0.45 |
POLN |
polymerase (DNA directed) nu |
6958 |
0.18 |
chr3_31255606_31255886 | 0.45 |
ENSG00000222983 |
. |
14461 |
0.26 |
chr3_71450987_71451266 | 0.45 |
FOXP1 |
forkhead box P1 |
97215 |
0.08 |
chr2_30467105_30467275 | 0.45 |
LBH |
limb bud and heart development |
12144 |
0.24 |
chr6_6660202_6660415 | 0.45 |
LY86-AS1 |
LY86 antisense RNA 1 |
37304 |
0.21 |
chr19_8813606_8813968 | 0.45 |
ACTL9 |
actin-like 9 |
4615 |
0.22 |
chr7_50417589_50418702 | 0.44 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
50900 |
0.15 |
chr5_14598149_14598547 | 0.44 |
FAM105A |
family with sequence similarity 105, member A |
16464 |
0.23 |
chr6_6611197_6611375 | 0.44 |
LY86-AS1 |
LY86 antisense RNA 1 |
11642 |
0.25 |
chr14_95930383_95930534 | 0.44 |
SYNE3 |
spectrin repeat containing, nuclear envelope family member 3 |
7932 |
0.21 |
chr6_159107432_159107778 | 0.44 |
SYTL3 |
synaptotagmin-like 3 |
23410 |
0.17 |
chr17_8856121_8856323 | 0.44 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
12802 |
0.23 |
chr15_38959074_38959400 | 0.44 |
C15orf53 |
chromosome 15 open reading frame 53 |
29562 |
0.22 |
chr5_109193839_109194454 | 0.44 |
AC011366.3 |
Uncharacterized protein |
24737 |
0.26 |
chr7_50347648_50348106 | 0.44 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
440 |
0.9 |
chr9_129984411_129984993 | 0.44 |
RP13-225O21.2 |
|
516 |
0.73 |
chr17_29636843_29637002 | 0.44 |
EVI2B |
ecotropic viral integration site 2B |
4180 |
0.15 |
chr15_69083761_69083930 | 0.44 |
ENSG00000265195 |
. |
10419 |
0.23 |
chr13_46747571_46748374 | 0.44 |
ENSG00000240767 |
. |
4089 |
0.19 |
chr15_64099770_64100081 | 0.44 |
HERC1 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 |
26159 |
0.2 |
chr7_158936629_158936995 | 0.44 |
VIPR2 |
vasoactive intestinal peptide receptor 2 |
732 |
0.8 |
chr2_68970379_68970530 | 0.44 |
ARHGAP25 |
Rho GTPase activating protein 25 |
8440 |
0.26 |
chr3_99594741_99594932 | 0.44 |
FILIP1L |
filamin A interacting protein 1-like |
112 |
0.98 |
chr2_182030324_182030499 | 0.44 |
ENSG00000266705 |
. |
139968 |
0.05 |
chr4_40239897_40240335 | 0.44 |
RHOH |
ras homolog family member H |
38152 |
0.16 |
chr7_76033311_76033487 | 0.43 |
SRCRB4D |
scavenger receptor cysteine rich domain containing, group B (4 domains) |
5613 |
0.17 |
chr12_88973642_88973896 | 0.43 |
KITLG |
KIT ligand |
469 |
0.8 |
chr13_60970205_60970411 | 0.43 |
TDRD3 |
tudor domain containing 3 |
283 |
0.94 |
chr1_63261615_63261766 | 0.43 |
ATG4C |
autophagy related 4C, cysteine peptidase |
10786 |
0.27 |
chr15_94830873_94831050 | 0.43 |
MCTP2 |
multiple C2 domains, transmembrane 2 |
10469 |
0.33 |
chr11_65696195_65696346 | 0.43 |
DRAP1 |
DR1-associated protein 1 (negative cofactor 2 alpha) |
9075 |
0.08 |
chr17_1774569_1774930 | 0.43 |
RPA1 |
replication protein A1, 70kDa |
7580 |
0.16 |
chr6_36114774_36114972 | 0.43 |
ENSG00000221743 |
. |
6508 |
0.18 |
chr8_1320967_1321354 | 0.43 |
DLGAP2 |
discs, large (Drosophila) homolog-associated protein 2 |
128372 |
0.06 |
chr17_66341426_66341824 | 0.43 |
ARSG |
arylsulfatase G |
53966 |
0.11 |
chr4_40222692_40222948 | 0.43 |
RHOH |
ras homolog family member H |
20856 |
0.2 |
chr2_222392100_222392498 | 0.43 |
ENSG00000221432 |
. |
7922 |
0.24 |
chr1_65413051_65413432 | 0.43 |
JAK1 |
Janus kinase 1 |
18946 |
0.23 |
chr14_100559814_100559997 | 0.43 |
EVL |
Enah/Vasp-like |
3379 |
0.18 |
chr15_63898445_63898817 | 0.43 |
USP3-AS1 |
USP3 antisense RNA 1 |
4843 |
0.21 |
chr6_90074063_90074313 | 0.43 |
UBE2J1 |
ubiquitin-conjugating enzyme E2, J1 |
11621 |
0.19 |
chr5_49959500_49959784 | 0.43 |
PARP8 |
poly (ADP-ribose) polymerase family, member 8 |
2091 |
0.49 |
chrX_154493931_154494082 | 0.43 |
RAB39B |
RAB39B, member RAS oncogene family |
132 |
0.96 |
chr3_109524806_109525056 | 0.43 |
ENSG00000265956 |
. |
203256 |
0.03 |
chr10_6968600_6968992 | 0.43 |
PRKCQ |
protein kinase C, theta |
346533 |
0.01 |
chr5_14559897_14560191 | 0.43 |
FAM105A |
family with sequence similarity 105, member A |
21840 |
0.23 |
chr8_102210801_102210952 | 0.42 |
ZNF706 |
zinc finger protein 706 |
3009 |
0.33 |
chr11_65553168_65553319 | 0.42 |
OVOL1 |
ovo-like zinc finger 1 |
1250 |
0.26 |
chr6_33871752_33872302 | 0.42 |
ENSG00000221697 |
. |
95801 |
0.06 |
chr8_134076793_134077503 | 0.42 |
SLA |
Src-like-adaptor |
4545 |
0.29 |
chr16_10483688_10483856 | 0.42 |
ATF7IP2 |
activating transcription factor 7 interacting protein 2 |
3854 |
0.26 |
chr6_2721520_2721671 | 0.42 |
MYLK4 |
myosin light chain kinase family, member 4 |
29559 |
0.18 |
chr3_31504876_31505139 | 0.42 |
ENSG00000238727 |
. |
67578 |
0.12 |
chr1_9304458_9304730 | 0.42 |
H6PD |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
4691 |
0.22 |
chr6_149567574_149567725 | 0.42 |
RP1-111D6.2 |
|
2512 |
0.29 |
chr1_182598624_182598819 | 0.42 |
RGS16 |
regulator of G-protein signaling 16 |
25178 |
0.17 |
chr2_136887722_136888188 | 0.42 |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
12220 |
0.28 |
chr17_61783924_61784215 | 0.42 |
STRADA |
STE20-related kinase adaptor alpha |
2254 |
0.24 |
chr12_92796420_92796828 | 0.42 |
RP11-693J15.4 |
|
18683 |
0.18 |
chr6_159475929_159476267 | 0.42 |
TAGAP |
T-cell activation RhoGTPase activating protein |
9914 |
0.2 |
chr14_102281735_102281949 | 0.42 |
CTD-2017C7.2 |
|
5184 |
0.16 |
chr8_126518150_126518406 | 0.42 |
ENSG00000266452 |
. |
61471 |
0.13 |
chr8_102149880_102150167 | 0.42 |
ENSG00000202360 |
. |
164 |
0.97 |
chr15_102062313_102062652 | 0.42 |
PCSK6 |
proprotein convertase subtilisin/kexin type 6 |
32295 |
0.19 |
chr12_12621200_12621432 | 0.42 |
DUSP16 |
dual specificity phosphatase 16 |
52743 |
0.13 |
chr15_38942394_38942965 | 0.42 |
C15orf53 |
chromosome 15 open reading frame 53 |
46120 |
0.16 |
chr4_39028874_39029217 | 0.42 |
TMEM156 |
transmembrane protein 156 |
4996 |
0.23 |
chr5_56127642_56127857 | 0.42 |
MAP3K1 |
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
16348 |
0.16 |
chr12_77099684_77099835 | 0.42 |
ZDHHC17 |
zinc finger, DHHC-type containing 17 |
57609 |
0.15 |
chr7_97880016_97880190 | 0.42 |
TECPR1 |
tectonin beta-propeller repeat containing 1 |
1136 |
0.49 |
chr2_99165408_99165595 | 0.42 |
INPP4A |
inositol polyphosphate-4-phosphatase, type I, 107kDa |
28989 |
0.18 |
chr8_26435600_26435751 | 0.42 |
DPYSL2 |
dihydropyrimidinase-like 2 |
246 |
0.95 |
chr4_95373883_95374100 | 0.42 |
PDLIM5 |
PDZ and LIM domain 5 |
897 |
0.74 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 0.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.5 | 1.9 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.5 | 1.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.5 | 1.9 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 1.8 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.4 | 1.7 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.4 | 0.7 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.3 | 1.0 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.3 | 1.0 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.3 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 2.5 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 0.9 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.3 | 0.9 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.3 | 0.6 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.3 | 0.6 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.3 | 1.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.3 | 0.3 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.3 | 1.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.8 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.5 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.3 | 0.8 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 0.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 0.5 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) negative regulation of T cell mediated immunity(GO:0002710) |
0.3 | 0.5 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.2 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 2.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 1.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.2 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 1.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.7 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 0.4 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 1.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.9 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.6 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 0.8 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.6 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 2.0 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 0.2 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.2 | 1.6 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.8 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 1.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.8 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 1.0 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 1.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 4.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.2 | 0.2 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.2 | 0.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.4 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.2 | 0.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.6 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.2 | 0.2 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.2 | 0.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 1.6 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.2 | 0.5 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.5 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 | 0.2 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.2 | 0.5 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.2 | 0.5 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 1.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.8 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.5 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.6 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 1.4 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.2 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.2 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.4 | GO:0043368 | positive T cell selection(GO:0043368) |
0.1 | 0.4 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.1 | 0.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.1 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.3 | GO:0002693 | regulation of cellular extravasation(GO:0002691) positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.1 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.1 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.3 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 9.3 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.1 | 0.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.7 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.7 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.4 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 0.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.7 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.4 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.4 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 1.0 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.1 | 0.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.3 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.6 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.4 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.5 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.1 | 0.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.2 | GO:0036230 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.1 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 1.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.5 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.4 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.1 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.1 | GO:0032649 | regulation of interferon-gamma production(GO:0032649) |
0.1 | 0.3 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.1 | 0.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.6 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.5 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.6 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.6 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 1.0 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.4 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.8 | GO:0002429 | immune response-activating cell surface receptor signaling pathway(GO:0002429) |
0.1 | 0.6 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.1 | GO:0016577 | histone demethylation(GO:0016577) |
0.1 | 0.2 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.5 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 2.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.5 | GO:1902115 | regulation of organelle assembly(GO:1902115) |
0.1 | 0.5 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 1.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.2 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.1 | 2.5 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.2 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 1.2 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 0.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.2 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.1 | GO:1902622 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.6 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.5 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.7 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.2 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.1 | 0.2 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.2 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of reactive oxygen species biosynthetic process(GO:1903427) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.4 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.5 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 1.7 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.2 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 0.5 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.1 | GO:0031223 | auditory behavior(GO:0031223) |
0.1 | 0.3 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.1 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.1 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.3 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.6 | GO:0036314 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.1 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.1 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.1 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.1 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.2 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 2.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.1 | GO:1902749 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 0.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 2.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.4 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.1 | GO:0060294 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.2 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 2.6 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 1.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 1.3 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 1.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.2 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.1 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.2 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
0.1 | 1.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.7 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.5 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.2 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.2 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) detection of bacterial lipoprotein(GO:0042494) response to bacterial lipopeptide(GO:0070339) detection of bacterial lipopeptide(GO:0070340) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.1 | 0.2 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.1 | 0.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.7 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.1 | GO:0042991 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 0.3 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.6 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.1 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.2 | GO:0021754 | facial nucleus development(GO:0021754) |
0.1 | 0.1 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.1 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 0.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.6 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.8 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 1.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.2 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.5 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.1 | GO:0021756 | striatum development(GO:0021756) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.3 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 3.7 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.2 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.4 | GO:0030449 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.1 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.4 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.1 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.1 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.1 | 0.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.2 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.1 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.1 | 0.3 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.5 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.1 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.5 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.3 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 3.2 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 4.0 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.3 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.5 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.1 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.2 | GO:0044766 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.1 | GO:0006312 | telomere maintenance via recombination(GO:0000722) mitotic recombination(GO:0006312) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.1 | GO:0044068 | modulation by virus of host process(GO:0019054) modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.2 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.8 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 1.0 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.1 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.2 | GO:0015853 | adenine transport(GO:0015853) |
0.1 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.1 | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002460) |
0.1 | 0.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 1.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.1 | 0.1 | GO:0051798 | regulation of hair cycle(GO:0042634) positive regulation of hair cycle(GO:0042635) regulation of hair follicle development(GO:0051797) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.2 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.1 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.4 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.1 | 0.1 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.1 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) regulation of glial cell proliferation(GO:0060251) negative regulation of glial cell proliferation(GO:0060253) |
0.1 | 0.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 0.1 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.1 | 0.3 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.6 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.2 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.1 | 0.1 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 2.0 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.3 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:0072191 | ureter development(GO:0072189) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) kidney smooth muscle tissue development(GO:0072194) |
0.0 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.2 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.0 | 0.4 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 1.2 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.0 | GO:0032609 | interferon-gamma production(GO:0032609) |
0.0 | 0.1 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.6 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 3.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.0 | GO:1903224 | endodermal cell fate commitment(GO:0001711) endodermal cell fate specification(GO:0001714) endodermal cell differentiation(GO:0035987) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.2 | GO:0072505 | phosphate ion homeostasis(GO:0055062) monovalent inorganic anion homeostasis(GO:0055083) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.0 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.0 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0021778 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.9 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.2 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.2 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.0 | 0.2 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.0 | 0.3 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) negative regulation of striated muscle cell differentiation(GO:0051154) |
0.0 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.0 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.3 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.2 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.1 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
0.0 | 0.1 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.5 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.1 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.2 | GO:0051329 | mitotic interphase(GO:0051329) |
0.0 | 0.1 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.0 | 0.4 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.0 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.0 | 0.5 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.0 | 0.0 | GO:1904035 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.0 | 0.3 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.0 | 0.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 4.8 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.0 | GO:0060214 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.0 | 0.0 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.5 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.0 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.0 | 0.0 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.0 | 0.5 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.3 | GO:0048895 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.0 | 0.0 | GO:0003207 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.0 | 0.9 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.3 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 1.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.0 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.0 | 1.7 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.7 | GO:0050863 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.0 | 0.0 | GO:0045684 | negative regulation of collagen biosynthetic process(GO:0032966) positive regulation of epidermis development(GO:0045684) |
0.0 | 0.1 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 1.6 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.1 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.5 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.0 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.0 | 0.0 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.0 | 0.1 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.0 | 0.1 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.0 | 0.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.1 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 1.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:0006241 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.0 | 0.1 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.5 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.1 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.0 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.0 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
0.0 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
0.0 | 0.1 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.0 | 0.0 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.0 | 0.3 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.0 | GO:0015904 | tetracycline transport(GO:0015904) |
0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.0 | 0.5 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0033131 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.0 | 0.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 3.6 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.4 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.5 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.3 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.0 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.1 | GO:0098727 | maintenance of cell number(GO:0098727) |
0.0 | 0.1 | GO:0031033 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.0 | 0.4 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.0 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.2 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) negative regulation of cell projection organization(GO:0031345) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.2 | GO:0098657 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.0 | 0.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.1 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.8 | GO:0044782 | cilium assembly(GO:0042384) cilium organization(GO:0044782) |
0.0 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.3 | GO:0042113 | B cell activation(GO:0042113) |
0.0 | 0.2 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.1 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.0 | 0.8 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.0 | GO:0001821 | histamine secretion(GO:0001821) |
0.0 | 0.0 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 2.2 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.1 | GO:0051310 | mitotic metaphase plate congression(GO:0007080) metaphase plate congression(GO:0051310) |
0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.5 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.0 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 1.1 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 1.3 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.1 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 1.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.0 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.1 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 1.6 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.2 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 2.3 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.1 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.0 | 0.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:1903307 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) positive regulation of regulated secretory pathway(GO:1903307) |
0.0 | 0.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 2.0 | GO:0050776 | regulation of immune response(GO:0050776) |
0.0 | 0.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.0 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.0 | 0.3 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.2 | GO:0001947 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.0 | 0.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.3 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 1.4 | GO:0034728 | nucleosome organization(GO:0034728) |
0.0 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.3 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.0 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.0 | 0.0 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.0 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.2 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.0 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.3 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 3.6 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.0 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.0 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.5 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.0 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.0 | 0.0 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.2 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.3 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.0 | GO:0032623 | interleukin-2 production(GO:0032623) |
0.0 | 0.2 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.2 | GO:0051899 | membrane depolarization(GO:0051899) |
0.0 | 0.4 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0031054 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) pre-miRNA processing(GO:0031054) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.1 | GO:0045217 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.5 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.9 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.2 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.0 | 0.0 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.0 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.1 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.5 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 3.0 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.2 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.0 | 0.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.0 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0097028 | myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:0022037 | metencephalon development(GO:0022037) |
0.0 | 0.0 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.0 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.0 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.6 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.2 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.3 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.0 | GO:0022409 | positive regulation of cell-cell adhesion(GO:0022409) |
0.0 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.0 | GO:0032402 | melanosome transport(GO:0032402) |
0.0 | 0.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 1.4 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.2 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.2 | GO:0016073 | snRNA metabolic process(GO:0016073) snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.0 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) peroxisomal transport(GO:0043574) |
0.0 | 0.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.0 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 0.1 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.0 | 0.0 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.0 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.0 | 0.0 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 0.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
0.0 | 0.0 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 1.3 | GO:0006955 | immune response(GO:0006955) |
0.0 | 0.0 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.0 | 4.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 0.1 | GO:0055006 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.0 | 0.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.0 | GO:0014904 | myotube cell development(GO:0014904) |
0.0 | 0.0 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.0 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 1.2 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.0 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 3.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 0.5 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 1.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.2 | GO:0000803 | sex chromosome(GO:0000803) |
0.2 | 1.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 1.1 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 2.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.5 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 1.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.9 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.5 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 0.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 1.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 1.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.6 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.7 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.5 | GO:0098687 | chromosomal region(GO:0098687) |
0.1 | 1.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.6 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.9 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.2 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 2.9 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 2.8 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 0.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.5 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.4 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.2 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.3 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 0.7 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.9 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.2 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.1 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.3 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.1 | 0.8 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.5 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 6.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.4 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 1.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.2 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.3 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.6 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 2.4 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 1.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 2.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.5 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.0 | 0.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 1.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.1 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.0 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.7 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 1.3 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 1.7 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.5 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.4 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 1.2 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 1.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.6 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.5 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 2.6 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 1.4 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.2 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 1.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.7 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.3 | GO:0005675 | holo TFIIH complex(GO:0005675) carboxy-terminal domain protein kinase complex(GO:0032806) |
0.0 | 2.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.1 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 1.1 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 7.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 2.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.0 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.2 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) cell envelope(GO:0030313) periplasmic space(GO:0042597) |
0.0 | 0.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 1.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 1.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.6 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 1.9 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.1 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.4 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.0 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.3 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 1.5 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.3 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.0 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 38.0 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 1.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.3 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 13.6 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.2 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.0 | 0.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.2 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 5.0 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 4.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.2 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 2.5 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.4 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.0 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.5 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 6.1 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 38.6 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 7.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 46.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.3 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.0 | GO:0042581 | specific granule(GO:0042581) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 1.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 1.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 1.0 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 1.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 0.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 2.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 0.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.7 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 2.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 1.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 0.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 1.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.8 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 1.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.9 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.2 | 0.7 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.7 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 4.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 1.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 2.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.8 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 0.5 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 2.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.4 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 1.3 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 1.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.6 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 4.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.4 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 1.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 5.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.4 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 0.4 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.1 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.3 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.9 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.6 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 2.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.3 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.6 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 1.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 2.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.2 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 4.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.3 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.2 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 1.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 1.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 1.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.1 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.2 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 0.1 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 0.2 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 0.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.4 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 1.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.5 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 0.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 1.9 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.3 | GO:0000036 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.1 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.1 | 0.2 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 0.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.6 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.3 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 1.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 2.0 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.3 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.4 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.3 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 1.1 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 1.5 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 4.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.2 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.6 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 2.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 1.5 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.0 | 0.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 1.6 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 1.9 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.2 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.9 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 1.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.2 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.8 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 1.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.3 | GO:0032129 | histone deacetylase activity(GO:0004407) NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent protein deacetylase activity(GO:0034979) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.4 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.4 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.7 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.4 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 1.0 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.2 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.3 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 1.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 1.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 6.8 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.0 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.0 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.8 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.2 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.9 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.6 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.0 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 2.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.1 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 0.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 5.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 2.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 3.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 7.6 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.9 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 9.8 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.2 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.0 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 4.4 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.3 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.0 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.2 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.0 | 0.0 | GO:0070568 | RNA guanylyltransferase activity(GO:0008192) guanylyltransferase activity(GO:0070568) |
0.0 | 0.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 31.3 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.0 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.0 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 1.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.1 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.1 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.8 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.0 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.1 | GO:0022821 | calcium, potassium:sodium antiporter activity(GO:0008273) potassium ion antiporter activity(GO:0022821) |
0.0 | 0.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 4.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.9 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.0 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.0 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 5.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 15.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 2.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 4.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 5.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 1.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 7.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 2.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 2.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 4.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 3.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 3.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 3.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.2 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 1.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 1.5 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.7 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 2.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 4.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 4.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 8.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 4.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 0.9 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 3.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 1.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 1.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 2.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 3.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 2.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 2.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 4.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 4.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 1.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 3.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 2.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 3.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.5 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 2.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.7 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.1 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 0.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 4.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 0.9 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 1.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 3.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.0 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 3.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 1.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.5 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.8 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 1.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 1.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 1.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 1.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 4.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.3 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 1.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 2.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 1.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 1.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.3 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 1.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 1.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.0 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 3.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.0 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |